Treatment of dystonia and tics
Treatment of dystonia and tics continues to evolve. In dystonia, while oral agents such as benzodiazepines, baclofen and anticholinergics remain in use, botulinum toxin (BoNT) continues to be regarded as the treatment of choice for focal and segmental dystonia, but new preparations are being studied...
Main Authors: | Steven Bellows, Joseph Jankovic |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2020-01-01
|
Series: | Clinical Parkinsonism & Related Disorders |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2590112519300313 |
Similar Items
-
Dystonia, an overview; classification, etiology and treatment
by: Jeanette Koht, et al.
Published: (2017-01-01) -
Botulinum toxin for the treatment of dystonia and pain in corticobasal syndrome
by: Elisa Unti, et al.
Published: (2019-06-01) -
Factors Influencing the Surgical Decision in Dystonia Patients Referred for Deep Brain Stimulation
by: Carolina Gorodetsky, et al.
Published: (2021-07-01) -
Unmet needs in the management of cervical dystonia
by: Maria Fiorella Contarino, et al.
Published: (2016-09-01) -
FDA Approvals and Consensus Guidelines for Botulinum Toxins in the Treatment of Dystonia
by: Lauren L. Spiegel, et al.
Published: (2020-05-01)